Clinical Trials Directory

Trials / Unknown

UnknownNCT04963140

Self-Management Of Asthma By Forced Oscillation Technique

Optimal Self-Management Of Asthma By Forced Oscillation Technique: a Randomised Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Restech Srl · Industry
Sex
All
Age
6 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Self-management strategies for asthma, including patients engagement and adherence to personalised action plans with advice on recognizing and responding to deterioration in control with effective treatments can improve asthma outcomes and possibly reduce the risk of future exacerbations. However, the real-life evidence is that asthma control remains sub-optimal in the majority of cases, thus increasing the related socio-economic costs worldwide. Because an increased variability of lung function remains a hallmark of poor asthma control and exacerbations, its assessment over time could contribute to the success of self-management plans. Previous studies have shown the potential of Forced Oscillation Technique (FOT) as a tool for monitoring increased variability of airway obstruction and for identifying the onset of acute deterioration of airway function. The aim of this study is to test the hypothesis that a personalised self-management plan including FOT improves asthma control and reduces number of days with increased symptoms compared to conventional asthma treatment.

Conditions

Interventions

TypeNameDescription
OTHEROptimized self-management of asthmaShort-term increase of asthma medication (as prescribed by the study doctor at enrolment) if an increased risk of asthma exacerbations is detected by the home monitoring device
OTHERConventional self-management of asthmaShort-term increase of asthma medication (as prescribed by the study doctor at enrolment) is based on subject's self-perception of symptoms

Timeline

Start date
2020-11-16
Primary completion
2024-04-01
Completion
2024-09-01
First posted
2021-07-15
Last updated
2023-02-13

Locations

10 sites across 3 countries: Australia, France, Italy

Source: ClinicalTrials.gov record NCT04963140. Inclusion in this directory is not an endorsement.